Allogeneic bone marrow transplantation

Allogeneic bone marrow transplantation (ABMT) is a medical procedure in which a patient receives healthy bone marrow cells from a compatible donor who is not genetically identical to them. This procedure is primarily utilized to treat patients with various hematological disorders, genetic conditions, and some forms of cancer.

Bone Marrow Transplant

Overview

The bone marrow is a spongy tissue located within the large bones of the body. It contains stem cells that produce the body's blood cells: red blood cells, white blood cells, and platelets. In some instances, diseases or treatments like chemotherapy can damage or destroy the bone marrow, impairing its ability to function properly. In such cases, a bone marrow transplant can become a potential lifesaving procedure.

Indications

There are several reasons why an allogeneic bone marrow transplant may be recommended:

• Hematological Disorders: Conditions like leukemia, lymphoma, and multiple myeloma.
• Genetic Disorders: Conditions such as sickle cell anemia, thalassemia, and aplastic anemia.
• Immune System Disorders: Conditions like severe combined immunodeficiency (SCID) or Wiskott-Aldrich syndrome.
• After High-Dose Chemotherapy or Radiation: In cases where these treatments destroy the bone marrow.

Donor Selection

For an allogeneic bone marrow transplant to be successful, the donor's bone marrow must be a close match to the patient's. This involves testing the human leukocyte antigen (HLA) of both the donor and the recipient. While family members, especially siblings, are often the best matches, many patients also find matches through national and international bone marrow registries.

Procedure

• Conditioning: Prior to the transplant, the patient undergoes a process called conditioning, which involves receiving high doses of chemotherapy or radiation. This helps in destroying the patient's existing bone marrow and any cancerous cells.
• Transplantation: After conditioning, the patient receives the donor's bone marrow cells through an intravenous (IV) line. This procedure is similar to a blood transfusion.
• Engraftment: Over the next several weeks, the transplanted bone marrow starts to produce new blood cells in the patient's body, a process termed engraftment.
• Recovery: The patient is closely monitored for complications, and might receive medications to prevent graft-versus-host disease (GVHD), a condition where the donor's cells attack the patient's body.

Complications

Like all medical procedures, allogeneic bone marrow transplantation can come with risks:

• Graft-versus-host disease (GVHD): As mentioned earlier, this is when the donor's immune cells attack the patient's tissues.
• Infections: Due to weakened immunity post-transplant.
• Organ Damage: Some organs may get damaged due to the high doses of chemotherapy or radiation given during conditioning.
• [[Graft failure]: Sometimes, the transplanted bone marrow does not start producing new blood cells.

Outlook

The success of an allogeneic bone marrow transplant largely depends on how closely the donor and recipient match, the patient's overall health, the disease being treated, and other factors. Over the years, advancements in the field have led to improved outcomes and reduced complications.

See Also

• Autologous bone marrow transplantation
• Hematopoietic stem cell transplantation
• Bone marrow registry

Allogeneic bone marrow transplantation Resources
Latest articles Most recent articles Ongoing trials	Wikipedia